Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study - Concepedia

Concepedia

Publication | Open Access

Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study

DOI Full Paper Access

73

Citations

27

References

2021

Year

Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María‐Eugenia Zaballa, Giovanni Piumatti, Matteo Coen, Amandine Berner, Pauline Darbellay Farhoumand, Pauline Vetter

Clinical Infectious Diseases

Abstract

Seroconversion after SARS-CoV-2 infection confers protection against reinfection lasting at least 8 months. These findings could help global health authorities establishing priority for vaccine allocation.

References

	Year	Citations

Page 1